The accumulation of macrophages in obese adipose tissue (AT) and their polarization into classically activated (inflammatory) M1 cells are critically involved in the inflammation of AT and metabolic dysregulation in obesity 1,2 . In contrast to the extensively studied chemokinedriven recruitment of monocytes and macrophages to AT 3-5 , little information exists about mechanisms that contribute to the retention of macrophages in AT 6 . The close proximity of inflammatory macrophages to adipocytes in obese AT, especially in regions designated 'crown-like structures' (CLSs) 1 , suggests that direct adhesive macrophage-adipocyte interactions might constitute a macrophageretention mechanism in AT. Direct adhesive interactions between immune cells and other cell types are mediated largely by leukocyte integrins 7 . However, whether integrin-dependent adhesion mediates the retention of macrophages in obese AT and contributes to inflammation-related metabolic dysregulation in obesity has not yet been investigated.
The accumulation of macrophages in obese adipose tissue (AT) and their polarization into classically activated (inflammatory) M1 cells are critically involved in the inflammation of AT and metabolic dysregulation in obesity 1, 2 . In contrast to the extensively studied chemokinedriven recruitment of monocytes and macrophages to AT [3] [4] [5] , little information exists about mechanisms that contribute to the retention of macrophages in AT 6 . The close proximity of inflammatory macrophages to adipocytes in obese AT, especially in regions designated 'crown-like structures' (CLSs) 1 , suggests that direct adhesive macrophage-adipocyte interactions might constitute a macrophageretention mechanism in AT. Direct adhesive interactions between immune cells and other cell types are mediated largely by leukocyte integrins 7 . However, whether integrin-dependent adhesion mediates the retention of macrophages in obese AT and contributes to inflammation-related metabolic dysregulation in obesity has not yet been investigated.
Beyond serving as energy-storage organ, white AT has a homeostatic role in energy dissipation. The energy-dispensing function of AT is mediated by upregulation of the expression of the uncoupling protein UCP1, which uncouples oxidative phosphorylation from ATP synthesis and thereby induces thermogenic activity in white AT [8] [9] [10] . This function is attributed largely to a subtype of 'beige' adipocytes.
These cells have inducible expression of UCP1, principally in response to exposure to cold, and thus share functional properties with brown adipocytes, such as thermogenic ability 9, [11] [12] [13] . As beige fat also exists in humans 13 , beige adipogenesis represents a potentially important therapeutic target in obesity 13 . Beige adipogenesis can be derived not only from the generation of beige adipocytes from committed progenitor cells but also from the transdifferentiation of white adipocytes into beige cells 9 . Notably, cells of type 2 immunity stimulate beige adipogenesis in lean AT 14 .
Notably, the expression of UCP1 and the energy-dissipating activity of white AT are diminished in adiposity [15] [16] [17] , although the mechanistic underpinnings involved have remained obscure. Exacerbated inflammation, including a shift from an M2 (anti-inflammatory) macrophage state toward a predominantly pro-inflammatory M1 macrophage state is a hallmark of obese white AT 1,2 . However, little evidence exists indicating that inflammation can impede thermogenic beige adipogenesis in obesity 18 . Hypothetically, inflammatory macrophages in obese AT might secrete factors that interfere with beige adipogenesis. Alternatively (or additionally, given the proximity of macrophages and adipocytes in obese AT), adhesive interactions between these two cell types could conceivably contribute to the inhibition of beige adipogenesis. That hypothesis was confirmed in our study here, which demonstrated that the interaction between α 4 integrin 7 on M1-polarized inflammatory macrophages and its counter-receptor VCAM-1 ('vascular cell adhesion molecule-1') on adipocytes in obese AT initiated a self-sustained inflammatory cycle that downregulated the expression of UCP1 in adipocytes in a manner dependent on the kinase Erk. Conversely, genetic or pharmacological blockage of α 4 integrin led to enhanced beige adipogenesis and prevented the metabolic dysregulation of obese AT.
RESULTS

Macrophage-adipocyte adhesive interactions in obese AT
To study macrophage-adipocyte interactions in obese AT, we focused on integrin adhesion receptors involved in leukocyte trafficking and cell-cell adhesion 19 . In this context, the integrins α 4 β 1 and α L β 2 are major participants that mediate the adhesive functions of monocytes and macrophages by recognizing their counter-receptors, VCAM-1 and ICAM-1, respectively, on target cells 7, 20 . We performed adoptive-transfer experiments to identify the integrin receptors involved in macrophage accumulation in obese AT. To bypass the embryonic lethality of the deletion of α 4 integrin (encoded by Itga4), we studied mice with inducible Itga4 deficiency 21 , generated by breeding of mice with loxP-flanked ('floxed') Itga4 alleles (Itga4 f/f ) with mice that have transgenic expression of Cre recombinase driven by the interferoninducible gene Mx1 (Mx1-Cre), in which Cre activity is induced by the synthetic RNA duplex poly(I:C) 21 (Mx1-Cre + Itga4 f/f ; called 'Cre + α 4 f/f ' here). Cre activity is induced in several tissues in Mx1-Cre mice; however, the main recombinase activity of Cre is present in hematopoietic system and liver 22, 23 . Itga4 is expressed predominantly in hematopoietic cells 21, 24, 25 , whereas Itga4 expression in isolated liver parenchymal cells was very low, relative to that in hematopoietic cells (data not shown). After administration of poly(I:C) to Cre + α 4 f/f mice, robust reduction in the expression of α 4 integrin was observed in monocytes isolated from the bone marrow of these mice (Supplementary Fig. 1a ), consistent with a published report on Mx1-Cre + Itga4 f/f mice 21 . and Cre + α 4 f/f monocytes-macrophages in the draining lymph nodes of the SAT (SAT dLN) and those of the VAT (VAT dLN) (b); all results are presented relative to those of Cre − α 4 f/f cells, set as 100%. (d) Vcam1 mRNA expression in the VAT and SAT of lean wild-type mice fed a normal-fat diet (ND; n = 8) or obese mice fed an HFD (n = 10) (left), in mature adipocytes from the VAT and SAT of lean mice fed a normal diet (n = 6) or obese mice fed an HFD (n = 6) (middle), and in CD31 + endothelial cells from SAT of lean mice fed a normal diet (n = 5 mice) or obese mice fed an HFD (n = 6 mice) (far right); results were normalized to those of 18S rRNA and are presented relative to those of mice fed a normal-fat diet, set as 1.
(e) Expression of Vcam1 mRNA in CD45 − CD31 + endothelial cells and adipocytes (horizontal axis) from the SAT of obese mice; results are presented relative to those of endothelial cells, set as 1. (f) Flow cytometry (left) analyzing the surface expression of VCAM-1 on primary mouse adipocytes left untreated (UT) or treated with TNF or palmitate (Palm) (key), and summary of results, presented as median fluorescence intensity (MFI) (right). Iso, isotype-matched control antibody. (g) Adhesion of bone-marrow mononuclear cells to 3T3-L1 adipocytes pretreated with TNF or palmitate (horizontal axis), assessed in the presence of ICAM-1-or VCAM-1-blocking antibodies or the respective isotype-matched control antibodies (ICAM-1 Iso or VCAM-1 Iso) (key); results are presented as the frequency of adherent cells. (h) Adhesion of bone-marrow mononuclear cells from Cre + α 4 f/f or Cre − α 4 f/f mice to 3T3-L1 adipocytes pretreated with TNF or palmitate (presented as in g). *P < 0.05 (Mann-Whitney U-test (a,c-f) or Student′s t-test (b,g,h)). Data are representative of two experiments with n = 5 (a) or n = 4 (c) recipient mice (a,c; mean + s.e.m.), are from one experiment with n = 5 recipient mice (b; mean + s.e.m.), are from one experiment (far right) or are representative of two experiments (all others) (d; mean + s.e.m.), are from one experiment with n = 6 mice (e; mean + s.e.m.), are representative of two experiments with n = 6 separate cell isolations (f; mean + s.e.m.), are from one experiment representative of three experiments with similar results (g; mean ± s.e.m. of n = 3 treatments per group), or are pooled from three experiments with separate cell isolations from n = 6 Cre + α 4 f/f mice and n = 8 Cre − α 4 f/f mice (h; mean ± s.e.m.).
A r t i c l e s
For adoptive transfer, we isolated CD11b + monocytes from the bone marrow of Cre + α 4 f/f mice 21 and labeled them with the green fluorochrome PKH67, and also isolated monocytes from their Itga4-sufficient (Cre − α 4 f/f ) control littermates and labeled these with the red fluorochrome PKH26, then injected the cells simultaneously, at a ratio of 1:1 in a competitive fashion, into wild-type mice with dietinduced obesity. We also implemented a similar experimental set up with monocytes from mice deficient or sufficient in α L integrin 26 . 7 d thereafter, we analyzed the accumulation and retention of the cells administered in AT; the majority of adoptively transferred monocytes that had accumulated in obese AT had acquired macrophage markers (Fig. 1a) . The accumulation of macrophages in both obese visceral AT (VAT) and inguinal subcutaneous AT (SAT) was dependent on the expression of α 4 integrin (Fig. 1a) but not that of α L integrin (data not shown). The diminished accumulation of Itga4-deficient macrophages relative to that of Itga4-sufficient macrophages in the SAT and VAT of obese wild-type mice was accompanied by a significantly greater number of Itga4-deficient monocytes-macrophages than Itga4-sufficient monocytes-macrophages in the draining lymph nodes of both SAT and VAT (Fig. 1b) . These findings suggested that α 4 integrin-deficient macrophages had egressed from SAT and VAT and hence had less retention therein. In contrast, the accumulation of T lymphocytes in obese SAT or VAT was independent of their expression of α 4 integrin (Fig. 1c) .
To further elucidate the role of α 4 integrin in the retention of macrophages in obese AT, we analyzed the expression of VCAM-1, the main counter-receptor of the integrin α 4 β 1 (ref. 27 ). Constitutive expression of Vcam1 was observed in lean SAT and VAT (Fig. 1d) . Vcam1 expression was massively upregulated in both SAT and VAT when mice developed diet-induced obesity (DIO) after being fed a high-fat diet (HFD) (Fig. 1d) . The upregulation of Vcam1 in AT was attributable predominantly to its increased expression in adipocytes rather than increased expression in endothelial cells (Fig. 1d) . The expression of Vcam1 by adipocytes in obese SAT was considerably higher than its expression in endothelium (Fig. 1e) . VCAM-1 was detectable in both 3T3-L1 adipocytes and primary adipocytes, and its expression was upregulated after treatment with tumor-necrosis factor (TNF) or palmitate, which are both hallmark factors of the obese AT environment 1, 4 (Fig. 1f and data not shown). We therefore hypothesized that the interaction between α 4 integrin and VCAM-1 might mediate the adhesion of macrophages to adipocytes in obese AT. Indeed, the adhesion of bone-marrow-derived mononuclear cells to adipocytes in vitro was blocked by antibody to VCAM-1 but not by antibody to the adhesion molecule ICAM-1 (Fig. 1g) . Consistent with that, α 4 -integrin-deficient mononuclear cells displayed less adhesion to adipocytes than that of α 4 -integrin-sufficient cells (Fig. 1h) . Thus, macrophage-adipocyte adhesion was dependent on the α 4 integrin-VCAM-1 interaction, and α 4 integrin mediated the retention of macrophages in obese AT.
Itga4 deficiency diminishes metabolic dysfunction in DIO
We then determined whether the α 4 -integrin-mediated adhesive interaction between macrophages and adipocytes in obese AT contributed to DIO-related metabolic dysregulation. Mice lacking α 4 integrin (Cre + α 4 f/f ) and their α 4 -integrin-sufficient (Cre − α 4 f/f ) control littermates were fed an HFD. By flow cytometry, we observed robust deletion of α 4 integrin in circulating monocytes and macrophages from the AT of Cre + α 4 f/f mice ( Supplementary Fig. 1b,c) .
f/f and Cre − α 4 f/f mice displayed no difference in terms of body-weight gain, fat mass or weight of liver, SAT or VAT (Fig. 2a,b and Supplementary Fig. 2a) . Similarly, Cre + α 4 f/f mice fed an HFD displayed no significant difference in the size of adipocytes in VAT or SAT compared with that of Cre − α 4 f/f mice ( Supplementary  Fig. 2b ). However, Cre + α 4 f/f mice with DIO displayed improved insulin sensitivity and lower glucose concentrations (although they had unaltered concentrations of triglyceride or cholesterol) compared with that of Cre − α 4 f/f mice (Fig. 2c,d and Supplementary  Fig. 2c) . No difference between Cre + α 4 f/f mice and Cre − α 4 f/f mice was observed in terms of their insulin sensitivity under normal-fat diet conditions (data not shown).
To study the accumulation and retention of macrophages in the AT of obese Cre + α 4 f/f and Cre − α 4 f/f mice, we performed immunofluorescence staining (using caveolin-1 and F4/80 to stain adipocytes 6, 28 and macrophages, respectively), followed by confocal microscopy of obese SAT from Cre + α 4 f/f and Cre − α 4 f/f mice. We found that the abundance of CLSs as well as that of non-CLS-associated macrophages in proximity to adipocytes was reduced in obese AT as a result of Itga4 deletion (Fig. 2e,f) . Those findings were independently verified by immunohistochemical analysis of F4/80-labeled macrophages and histological quantification, which demonstrated a significant reduction in the number of CLSs and non-CLS-associated macrophages in contact with adipocytes in obese SAT after loss of expression of α 4 integrin ( Supplementary Fig. 3a,b) . 
A r t i c l e s
To further substantiate our hypothesis that α 4 integrin mediated the macrophage-adipocyte interactions in obese AT, we quantified the area of contact of macrophages and adipocytes, as a measure of macrophage-adipocyte adhesion. This analysis revealed that macrophages had less contact with adipocytes after deletion of Itga4 (Supplementary Fig. 3c ). Moreover, three-dimensional reconstruction of macrophage-adipocyte interactions verified the diminished contact of macrophages with and spreading on adipocytes in Cre + α 4 f/f mice relative to that in their Cre − α 4 f/f littermates ( Supplementary  Fig. 4a-d) . Those effects were probably independent of netrin-1 (encoded by Ntn1), which contributes to the retention of macrophages in obese AT 6 , since deletion of Itga4 did not affect Ntn1 expression in obese SAT or VAT ( Supplementary Fig. 5a,b) .
To characterize the inflammatory milieu of the SAT and VAT of obese Cre + α 4 f/f and Cre − α 4 f/f mice, we studied the abundance of proinflammatory M1-like macrophages and of M2-like macrophages, defined by flow cytometry as F4/80 + CD11b + iNOS + CD206 − and F4/ 80 + CD11b + iNOS − CD206 + , respectively. We found significantly fewer M1 macrophages in both the SAT and VAT of obese Cre + α 4 f/f mice than in that of their Cre − α 4 f/f littermates, while the number of M2 macrophages in obese AT remained unaffected by deletion of Itga4 (Fig. 2g,h ). Those findings were confirmed by flow-cytometry staining of inflammatory macrophages as F4/80 + CD11b + CD11c + CD206 − and of M2-like macrophages as F4/80 + CD11b + CD11c − CD206 + (data not shown); CD11c has been used as a marker of inflammatory AT macrophages 29 . Furthermore, the lower abundance of M1 macrophages in both the VAT and SAT of Cre + α 4 f/f mice than in that of Cre − α 4 f/f mice was confirmed by the lower number of TNF-expressing macrophages (Fig. 2i,j) . In wild-type mice, M1-like macrophages from obese SAT and VAT displayed higher expression of α 4 integrin than that of M2-like macrophages (Fig. 2k) . These data suggested that α 4 integrin mediated direct adhesion of macrophages to VCAM-1-expressing adipocytes and thus the retention of inflammatory macrophages within obese AT, AT inflammation and insulin resistance.
Enhanced beige adipogenesis of Cre +  4 f/f mice with DIO To understand the improved metabolic phenotype of α 4 -integrindeficient mice, we performed metabolic-cage analysis. Cre + α 4 f/f mice with DIO displayed greater energy expenditure than that of their Cre − α 4 f/f littermates (Fig. 3a) , although no difference was detected in their respiratory-exchange ratio (data not shown). The absence of a difference between Cre − α 4 f/f and Cre + α 4 f/f mice in body weight during DIO, despite the greater energy expenditure of Cre + α 4 f/f mice, could be attributed to the greater food intake of these mice (Supplementary Fig. 6a ).
To elucidate the finding of greater energy expenditure in obese Cre + α 4 f/f mice, we assessed the expression of genes encoding thermogenic products in white AT or brown AT (BAT). The expression of both mRNA and protein from the gene encoding the key thermogenic protein UCP1 (Ucp1) and of mRNA from genes encoding products related to brown-fat identity (Cidea ('cell death-inducing DNA fragmentation factor-like effector A') and Cox8b ('cytochrome c oxidase subunit 8b')) was upregulated in the SAT of Cre + α 4 f/f mice relative to that in the SAT of Cre − α 4 f/f mice (Fig. 3b,c) . Consistent with that, Cre + α 4 f/f mice challenged with exposure to a cold temperature (4 °C) sustained a higher core temperature, accompanied by enhanced expression of UCP1, compared with that of their Cre − α 4 f/f littermates (Fig. 3d,e) . Immunohistochemical analysis of UCP1 revealed a greater presence of beige-adipogenesis areas in the SAT of Cre + α 4 f/f mice exposed to the cold than in that of their Cre − α 4 f/f counterparts similarly exposed to the cold (Fig. 3f) . Although deletion of Itga4 enhanced beige adipogenesis in the SAT of obese mice, it had no effect on the expression of genes encoding thermogenic products in the VAT, or on the expression of such genes and the abundance of UCP1 protein, as assessed by immunohistochemistry, in the BAT ( Supplementary  Fig. 6b,c) . To address that difference, we compared Vcam1 expression in SAT with that in BAT and found it was much higher in the adipocytes of obese SAT than in those of obese BAT (Fig. 3g) . That finding provided an explanation for the finding that deletion of Itga4 increased predominantly thermogenic beige adipogenesis in obese SAT without affecting the expression of genes encoding thermogenic products in BAT. Therefore, the greater energy-dissipating activity of obese Cre + α 4 f/f mice was derived from a more thermogenic SAT.
Pharmacological inhibition of  4 integrin in obesity
As enhanced beige adipogenesis of white AT is linked to improved metabolic control, approaches to stimulate white-fat beiging have emerged as an attractive anti-obesity therapeutic strategy 30 . We therefore assessed the therapeutic potential of pharmacological inhibition of α 4 integrin in wild-type mice given an inhibitor of α 4 integrin that 'preferentially' blocks α 4 β 1 or vehicle control, via a mini-osmotic pump, for 6 weeks after establishment of DIO. Mice with DIO that received the α 4 inhibitor exhibited improved insulin sensitivity and lower serum concentrations of insulin, glucose and cholesterol compared with that of mice treated with the vehicle (Fig. 4a-c) . Analysis of obese SAT by confocal microscopy revealed that inhibition of α 4 integrin reduced the abundance of macrophages in contact with adipocytes (Fig. 4d) .
Histological quantification demonstrated that the number of both CLSs and of non-CLS-associated macrophages in proximity to adipocytes in the SAT was significantly decreased by blockade of α 4 integrin (Fig. 4e) . Moreover, flow-cytometry analysis revealed that the abundance of M1-like macrophages (defined as F4/80 + CD11b + iNOS + CD206 − ) was significantly lower in the SAT of obese mice that received the α 4 inhibitor than in that of mice treated with the vehicle, whereas the number of M2-like macrophages in obese SAT remained unaffected by blockade of α 4 integrin (Fig. 4f) . Furthermore, inhibition of α 4 integrin in mice with DIO led to enhanced beige adipogenesis of the SAT, as indicated by elevated expression of Ucp1 mRNA and UCP1 protein in the SAT (Fig. 5a,b) but not in the VAT (data not shown), relative to that in mice treated with the vehicle control. 
A r t i c l e s
We also tested the α 4 inhibitor in ob/ob mice, a model of genetically induced obesity. The ob/ob mice treated with the α 4 inhibitor displayed improved insulin sensitivity, accompanied by enhanced thermogenesis, higher expression of UCP1 protein and ameliorated accumulation of inflammatory macrophages in the SAT, relative to that of ob/ob mice treated with the vehicle ( Supplementary  Fig. 7a-d) . Together our findings suggested that functional inactivation of macrophage interactions in obese AT mediated by α 4 integrin ameliorated obesity-related metabolic dysregulation via improved beige adipogenesis.
To substantiate the mechanism of action of the pharmacological inhibition of α 4 β 1 , we treated mice with DIO with the α 4 inhibitor or vehicle, then exposed them to conditions of thermoneutrality (30 °C), wherein UCP1 is functionally incompetent 12, 14 . In contrast to the improved insulin sensitivity and enhanced expression of Ucp1 as a result of treatment with the α 4 inhibitor in mice kept at 22 °C, relative to that of their counterparts treated with vehicle at 22 °C, these differences were largely abolished at thermoneutrality (Fig. 5c-e) .
At thermoneutrality, slightly (but not significantly) higher expression of Ucp1 was observed in mice with DIO treated with the α 4 inhibitor than in their counterparts treated with vehicle (Fig. 5e) . The abundance of M1-macrophages was lower in both the SAT and VAT of mice treated with the α 4 inhibitor than in that of their counterparts treated with vehicle, under thermoneutral conditions (Fig. 5f) . Hence, the α 4 inhibitor failed to improve insulin sensitivity or beige adipogenesis under thermoneutral conditions despite reducing the accumulation of macrophages, which suggested crucial involvement of UCP1 in the mechanism whereby pharmacological inhibition of α 4 promoted the beige adipogenesis of white AT and prevented obesity-related metabolic dysregulation.
Macrophage-adipocyte adhesion inhibits UCP1 expression Studies suggest that alternatively activated M2 macrophages promote beige adipogenesis in lean AT in a paracrine fashion 14 thus far, although it was suggested by our findings. Consistent with published findings 16, 18, 31 , the expression of UCP1 was lower, at level of Ucp1 mRNA and UCP1 protein, in obese SAT than in lean SAT (data not shown), which indicated that the predominance of inflammatory macrophages in obese SAT correlated with the inhibition of beige adipogenesis. To conclusively demonstrate that concept and to delineate its mechanistic underpinnings, we performed macrophage-primary adipocyte co-cultures. The adipocytes used were generated from pre-adipocytes isolated from the stromal vascular fraction (SVF) of wild-type mouse SAT that maintain their ability to express beige-fat-related genes, including Ucp1 (ref. 8). White and beige adipocytes have bidirectional interconversion properties 9,13,32 , probably because they originate from PDGFRα + bipotent precursor cells 33 . We added norepinephrine and triiodothyronine (T3) to primary adipocytes before the adipocyte-macrophage co-cultures performed here, to drive a beige-fat-like profile and activation of Ucp1 expression 34 ( Supplementary Fig. 8 ). For M1-like inflammatory macrophages, we cultured bone-marrow-derived macrophages (BMDMs) with the cytokine GM-CSF and stimulated them with lipopolysaccharide (LPS), or stimulated macrophages derived from obese SAT with LPS plus interferon-γ (IFN-γ) 35, 36 . When adipocytes were cultured in direct contact (in the same well) with pro-inflammatory M1-like BMDMs, the Ucp1 expression in adipocytes stimulated with norepinephrine and T3 was significantly lower than that in adipocytes stimulated similarly but cultured in the absence of M1-like BMDMs (Fig. 6a) . Similar results were obtained for adipocytes cultured in direct contact with pro-inflammatory macrophages derived from obese SAT and stimulated with LPS plus IFN-γ (Fig. 6b) . Consistent with that, deletion of Itga4 (in obese Cre + α 4 f/f mice) was associated with higher expression of Ucp1 in the SAT than in that of their obese Cre − α 4 f/f littermates (Fig. 3b) . Among fat pads with thermogenic potential (SAT and BAT), adipocytes in SAT had higher expression of VCAM-1 during obesity than did adipocytes in BAT (Fig. 3g) . The inhibition of Ucp1 expression mediated by the direct cell-cell contact of inflammatory macrophages with adipocytes was reversed by the α 4 inhibitor, which did not affect the expression of this thermogenic-protein-encoding gene by adipocytes in the absence of macrophages (Fig. 6a,b) . These data suggested that the inhibitory effect of inflammatory macrophages on beige adipogenesis required direct α 4 -integrin-dependent cell-to-cell adhesive interactions.
We generated M2-like macrophages by stimulating lean-SATderived macrophages with interleukin 4 (IL-4), then cultured them A r t i c l e s together with differentiated adipocytes. M2-like macrophages promoted Ucp1 expression by adipocytes when cultured with adipocytes in both direct-contact mode and non-contact mode (Transwell setup). Under both co-culture conditions, inhibition of α 4 integrin did not affect the Ucp1 expression in adipocytes triggered by M2-like macrophages (Fig. 6c,d) .
Studies have highlighted the opposing roles of the signaling pathways of the mitogen-activated protein kinases p38 (ref. 37 ) and Erk 38, 39 in beige adipogenesis and the regulation of UCP1, as they mediate stimulatory effects and inhibitory effects, respectively. We found that direct culture of inflammatory macrophages together with primary adipocytes resulted in lower abundance of phosphorylated p38 and greater abundance of phosphorylated Erk in adipocytes, relative to their abundance in adipocytes cultured alone (Fig. 6e,f) ; this provided a mechanistic basis for the inhibitory effect of inflammatory macrophages on the expression of Ucp1 by adipocytes. The reduction in the expression of Ucp1 by the presence of M1-like macrophages was reversed when adipocytes were pre-treated with an inhibitor of Erk (Fig. 6g) . Next, we sought to determine whether the α 4 -integrin-dependent inhibitory effect of inflammatory macrophages on beige adipogenesis was driven by regulation of the pathways of phosphorylated p38 and phosphorylated Erk. In support of that proposal, the abundance of phosphorylated p38 was increased, whereas that of phosphorylated Erk was decreased, when the direct contact between adipocytes and inflammatory macrophages was blocked by the α 4 inhibitor (Fig. 6h,i) .
In addition to the ability of white adipocytes to induce UCP1 expression 9, 10, 40 , progenitors of adipocytes can also differentiate into beige adipocytes 33, 41 . We therefore assessed whether direct contact with pro-inflammatory macrophages would also affect Ucp1 expression in the progenitors of adipocytes. First, we found that PDGFRα + Sca-1 + adipocyte progenitors from the SAT of obese mice displayed significantly higher expression of Vcam1 than that of their counterparts from that of lean mice (Fig. 6j) . Moreover, TNF significantly increased Vcam1 expression in adipocyte progenitors (Fig. 6k) . In addition, when adipocyte progenitors were cultured in the presence of pro-inflammatory M1-like macrophages (in a direct cell-cell contact assay), their expression of Ucp1 was significantly decreased relative to that of adipocyte progenitors cultured alone, in a manner dependent on the α 4 β 1 -VCAM-1 interaction (Fig. 6l) .
We next assessed whether the direct α 4 β 1 -VCAM-1 interaction between macrophages and adipocytes would also affect the inflammatory activation of macrophages and thereby lead to a self-sustained cycle of persistent inflammation of AT. Culture of macrophages on plates pre-coated with VCAM-1 enhanced their expression of TNF (Fig. 7a,b) , which is a cardinal marker of M1 macrophage polarization 2, 35, 42 . The VCAM-1-dependent upregulation of TNF in macrophages was abolished in the presence of the α 4 inhibitor (Fig. 7a) and in α 4 -integrin-deficient macrophages (Fig. 7b) . Consistent with that, inhibition of α 4 integrin or α 4 deficiency in macrophages prevented the enhanced TNF expression in macrophages that resulted from direct cell-cell contact with adipocytes (Fig. 7c,d) . Thus, the α 4 -integrin-dependent crosstalk of macrophages with adipocytes was bidirectional and promoted inflammatory activation of the former and blocked beige adipogenesis of the latter.
We then studied whether inflammatory macrophages could further contribute to the inhibition of beige adipogenesis by upregulating VCAM-1 expression in the adipocyte compartment. Since TNF enhanced VCAM-1 expression in adipocytes and TNF expression itself was upregulated by the direct macrophage-adipocyte contact, we explored whether macrophage-derived TNF could stimulate VCAM-1 expression in adipocytes. We therefore performed noncontact (Transwell) macrophage-adipocyte co-cultures. We observed upregulation of VCAM-1 expression in adipocytes cultured together with SAT-derived M1-like inflammatory macrophages (Fig. 7e) . This paracrine-induced increase in the expression of VCAM-1 in adipocytes via inflammatory macrophages was inhibited by antibody to TNF (Fig. 7e) . In contrast, the expression of VCAM-1 in adipocytes was not affected by culture (in a Transwell setup) with SAT-derived M2-like macrophages in either the presence of the α 4 inhibitor or its absence (Fig. 7f) .
Thus, the α 4 -integrin-dependent adhesive macrophage-adipocyte interaction promoted a self-sustained inflammatory loop in obese AT that involved inflammatory activation of macrophages and resulted in enhanced TNF production that further upregulated VCAM-1 expression in adipocytes. The direct α 4 -integrin-dependent macrophageadipocyte interaction also inhibited UCP1 expression, which might contribute to diminished beige adipogenesis in obesity.
Macrophage-adipocyte interactions in the human system We then determined whether the adhesive inflammatory macrophage-adipocyte interaction dependent on α 4 integrin-VCAM-1 also operated in the human system. At first, we observed an inverse correlation between the expression of UCP1 and that of VCAM1 in SAT samples obtained from patients undergoing abdominal surgery (Fig. 7g) . We also found that the expression of VCAM1 increased in human adipocytes (differentiated from pre-adipocytes) after stimulation with TNF or palmitate (Fig. 7h) . Moreover, the adhesion of human M1-like pro-inflammatory macrophages to adipocytes was partially inhibited by the α 4 inhibitor (Fig. 7i) . Culture of inflammatory macrophages together with primary adipocytes (with direct cell-cell contact) reduced the expression of UCP1 in the latter in a manner dependent on adhesion mediated by α 4 β 1 -VCAM-1 (Fig. 7j) . These data suggested that direct macrophage-adipocyte interactions might downregulate UCP1 expression in human SAT as well.
DISCUSSION
Beige adipogenesis linked with expression of the thermogenic protein UCP1 is a homeostatic function of the promotion of energy expenditure by lean AT 43 . In human and mouse obesity, beige adipogenesis becomes dysfunctional, and this phenomenon is associated with enhanced inflammation of AT 15, 17, 18, 33, 44, 45 . Here we established a self-sustained loop that linked inflammation of AT and retention of inflammatory macrophages with impaired beige adipogenesis in obesity. Specifically, α 4 -integrin-mediated adhesion of inflammatory macrophages to VCAM-1, the expression of which was augmented in adipocytes (and their progenitors) in obesity, inhibited UCP1 expression in an Erk-dependent way.
The enhanced abundance of inflammatory macrophages in obese AT might depend on the function of integrins such as α 4 β 1 on increased expression of monocyte-attracting chemokines 1, 20, 27, 29 or on local population expansion of macrophages 44 . It is conceivable that the mechanism for the α 4 -integrin-mediated retention of macrophages identified here might also facilitate the population expansion of macrophages in AT 44 . We found that TNF, the expression of which is elevated in obese AT 1, 46 , upregulated VCAM-1 expression in adipocytes and their progenitors and thereby promoted direct adhesive interactions of those cells with macrophages, dependent on α 4 integrin-VCAM-1. That interaction promoted the retention of macrophages in obese AT and drove further pro-inflammatory M1-like polarization, including increased TNF production; it thereby further enhanced the expression of VCAM-1 by adipocytes and sustained the direct macrophage-adipocyte interaction and hence perpetuated the inflammation of AT. Notably, the adhesion of macrophages to adipocyte VCAM-1 dependent on α 4 integrin inhibited UCP1 expression and thus beige adipogenesis, which thereby established a paramount paradigm of inflammation-driven metabolic dysfunction of obese AT.
In that context, the α 4 -integrin-mediated interaction of inflammatory macrophages with adipocytes downregulated signaling via p38 and upregulated signaling via Erk in the latter cells, which led to downregulation of Ucp1 expression, in accordance with published reports [37] [38] [39] . Furthermore, Erk signaling in adipocytes promotes insulin resistance and diabetogenic actions by regulating the function of the nuclear hormone receptor PPARγ 47 . Therefore, the mechanism mediated by α 4 integrin-VCAM-1 delineated here might regulate further detrimental actions of Erk signaling in adipocytes.
Our findings are consistent with those of a published study that used knock-in mice expressing mutant α 4 (α 4 (Y991A)) to demonstrate that inhibition of α 4 integrin signaling ameliorates DIO-related metabolic dysfunction 20 . However, our work has additionally introduced the new concept that α 4 -integrin-dependent direct adhesion of inflammatory macrophages to adipocytes inhibited UCP1 expression and has revealed a previously unknown self-sustained cycle that links inflammation of AT with impaired beige adipogenesis in obesity.
Analysis of VCAM-1 expression is usually confined predominantly to the vascular endothelium and hematopoietic cells 48, 49 . We found that enhanced VCAM-1 expression in obese AT 50 was derived predominantly from adipocytes. Moreover, the most prominent VCAM-1 expression by adipocytes was observed in the SAT (rather than the VAT or the BAT), which might explain the finding that genetic or pharmacological inhibition of α 4 integrin affected mainly UCP1 expression and beige adipogenesis in this particular fat pad. The α 4 -integrin-dependent adhesive interaction delineated might regulate beige adipogenesis in the human system, a proposal supported by the inverse correlation between the expression of VCAM-1 and that of UCP1 in human SAT. Notably, although multiple papers have described adhesive leukocyte-endothelium interactions that mediate the recruitment of inflammatory cells, little knowledge exists on mechanisms for the adhesion of macrophages with tissue-resident cells, or the functional consequences thereof for the local tissue environment. In this context, a new pathogenic principle arising from our work involves direct adhesive interactions between inflammatory cells and parenchymal cells. This previously unknown disease-promoting mechanism might underlie several other chronic inflammatory disorders and might be therapeutically important, as it is amenable to intervention. The mechanism presented here might be of therapeutic relevance, since we have pinpointed α 4 integrin as a potential target for intervention in obesity. Pharmacological inhibition of α 4 integrin promoted systemic insulin sensitivity by stimulating beige adipogenesis; such a therapeutic strategy has not been yet harnessed by current antidiabetic drugs and might merit further detailed investigation in preclinical settings.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
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Glutamax, penicillin-streptomycin and recombinant mouse GM-CSF (10 ng/ ml, PeproTech) for 7 d. GM-CSF-cultured BMDMs were stimulated with LPS (100 ng/ml; Invivogen) for 12 h to induce an inflammatory M1-like phenotype. BMDMs were harvested by using a non-enzymatic cell-dissociation solution (Sigma-Aldrich) and were counted before co-culture with adipocytes.
Primary pre-adipocytes isolated from the SVF of the SAT undergoing differentiation (described above) were treated on day 8 or 9 of their differentiation with T3 (10 nM) and norepinephrine (1 µM; Sigma Aldrich) for 3 h, to induce a thermogenic response 34 , and then washed before co-culture with BMDMs. For direct primary adipocyte-BMDM co-cultures, in which the cells were in contact with each other, adipocytes were cultured without or with BMDMs (5 × 10 4 ) for 1 h. Experiments were performed in the absence or presence of the α 4 inhibitor (ELND002; 1 nM) . In other experiments, adipocytes were pretreated with an Erk inhibitor (UO126, 10 µM, Sigma Aldrich) for 30 min and were washed with medium before the addition of M1-like polarized BMDMs. For adipocyte mRNA-expression analysis, cells were trypsinized, washed with PBS and separated from macrophages by CD45 negative selection using MACS magnetic beads (Miltenyi). Ucp1 mRNA expression was analyzed by qPCR; 18S rRNA was used for normalization.
For the detection of phosphorylated Erk1/2 and p38 in adipocytes after coculture with macrophages for 30 min, cells were harvested by trypsinization, washed with PBS and incubated with mouse Fc block and APC-conjugated rat antibody to mouse CD11b (M1/70) (both from BD) for 15 min on ice. After fixation with 4% paraformaldehyde for 10 min, cells were permeabilized by the 90% methanol, treated with 10% goat serum (Sigma Aldrich) and incubated with either rabbit antibody to mouse mitogen-activated protein kinase p44/42 phosphorylated at Thr202 and Tyr204 (p-Erk1/2) (0.5 µg/100 µl; Cell Signaling; catalog # 9101) or rabbit antibody to mouse p38 phosphorylated at Thr180 and Tyr182 (0.25 µg/100 µl; Cell Signaling, catalog # 4511) for 1 h at 22 °C. After washing, cells were incubated with goat anti-rabbit IgG (H+L) Alexa Fluor 488 (0.1 µg/100 µl; Invitrogen; catalog # A-11034) for 1 h at 22 °C. Median fluorescence intensity (MFI) was determined by flow cytometry (FACSCanto II, BD) after gating of adipocytes (defined as CD11b − cells).
In other experiments, co-cultures of adipocytes were performed with SATderived macrophages. For isolation of primary macrophages from SAT, SV cells were isolated from lean mice or obese C57BL/6 mice. Isolated SV cells were stained with anti-F4/80 Microbeads (Miltenyi Biotec), and macrophages were selected as F4/80 + cells by MACS columns. The isolated macrophages were cultured in complete RPMI-1640 medium with M-CSF (10 ng/ml, eBioscience) for 24 h. To obtain M1-like polarized macrophages, macrophages derived from obese SAT were additionally treated with LPS (100 ng/ml, Invivogen) and IFN-γ (20 ng/ml, BD) for 12 h, while for obtaining M2-like polarized macrophages, macrophages derived from lean SAT were treated with IL-4 (20 ng/ml, PeproTech) for 12 h.
In direct primary adipocyte-SAT-derived macrophage co-cultures, adipocytes pre-treated with T3 and norepinephrine were co-cultured without or with SAT-derived M1-like polarized macrophages (2 × 10 4 cells) for 1 h, as described above for adipocyte-BMDM co-cultures. In other experiments, adipocytes were co-cultured without or with SAT-derived M2-like polarized macrophages (2 × 10 4 cells) for 6 h. Experiments were performed in the absence or presence of the α 4 inhibitor (1 nM). The cells were trypsinized, and Ucp1 mRNA expression in adipocytes was analyzed by qPCR after their separation as CD45 − cells by MACS magnetic beads (Miltenyi Biotec).
The indirect primary adipocyte-primary SAT-derived macrophages cocultures, in which the cells were not in contact, were performed with 0.4-µm pore size Transwell inserts (Corning). T3-and norepinephrine-pre-treated primary adipocytes (lower compartment) were co-cultured for 6 h without or with SAT-derived M2-like polarized macrophages (2 × 10 4 cells) that were in the Transwell inserts, in the absence or presence of the α 4 inhibitor. At the end of the experiment, Transwell inserts were removed, adipocytes were washed, and Ucp1 mRNA expression was analyzed by qPCR.
In other experiments, M1-or M2-like polarized SAT-derived macrophages were seeded on 0.4-µm pore size Transwell inserts (0.4-µm pore size) at a density of 2 × 10 4 cells and co-cultured with primary adipocytes. The experiments with M2-like macrophages were performed in the absence or presence of the α 4 inhibitor. For M1-like macrophages, experiments were performed in the absence or presence of a TNF-blocking antibody (1 µg/ml, R&D; catalog # AF-410-NA). After incubation for 24 h, adipocytes were trypsinized and stained with an anti-VCAM-1 (clone 429, BD); VCAM-1 expression was analyzed by flow cytometry.
For adipocyte-progenitor-cell isolation, SV cells from SAT from lean C57BL/6 mice were washed with PBS containing 0.5% BSA (Sigma Aldrich), incubated with Fc block (BD) and stained with anti-CD31 (MEC 13.3 from BD), anti-CD45 (30-F11 from BioLegend), anti-Sca1 (D7 from BD) and anti-PDGFRα (APA5 from BD) for 20 min at 4 °C. Adipocyte progenitors were sorted as CD31 − CD45 − Sca1 + PDGRα + cells in a FACSAria II cell sorter (BD). The cells were seeded into culture dishes until they reached 70-80% confluence and then were transferred to 24-well plates (5 × 10 4 cells per well) before co-culture with BMDMs. Specifically, after 3 h of pre-treatment of adipocyte progenitors with T3 and norepinephrine, direct co-cultures of adipocyte progenitors with M1-like polarized BMDMs were performed for 1 h in the absence or presence of the α 4 inhibitor. Thereafter, Ucp1 mRNA abundance in adipocyte progenitors was determined by qPCR, after exclusion of BMDMs as described above. In other experiments, after isolation of SV cells and adipocyte-progenitor-cell sorting, the latter were seeded for 24 h in 48-well plates (2 × 10 4 cells per well) and then treated overnight with mouse recombinant TNF (20 ng/ml, R&D systems), and mRNA expression of Vcam1 was analyzed by qPCR.
Isolation of mature adipocytes, adipocyte progenitors and endothelial cells from AT. SAT, VAT and BAT from lean or obese C57BL/6 mice were digested with collagenase and filtered. After centrifugation, the floating cells representing the mature adipocytes were collected and washed three times with PBS, and RNA isolation was performed with Trizol. The SV cells in the pellet were washed with PBS containing 0.5% BSA and then were incubated with Fc block (BD) and stained with anti-CD31 (MEC 13.3 from BD), anti-CD45 (30-F11 from BioLegend), anti-Sca1 (D7 from BD) and anti-PDGFRα (APA5 from BD) for 20 min at 4 °C. After being washed, CD31 − CD45 − Sca1 + PDGRα + adipocyte progenitors or CD45 − CD31 + endothelial cells were sorted in a FACSAria II cell sorter (BD), and RNA from each individual population was isolated by Trizol.
Stromal vascular fraction (SVF) isolation and flow cytometry. SVF was prepared as reported 55, 59, 60 . In brief, inguinal SAT or VAT was isolated from euthanized mice, then was minced and digested for 60 min in DMEM containing collagenase type I (2 mg/ml per gram of tissue; Invitrogen) at 37 °C. Cell suspensions were then filtered through a 40-µm cell strainer and the SVF was collected as a pellet after centrifugation at 500g for 5 min. After RBC lysis, cells were stained with anti-CD45 (30-F11, BD), anti-F4/80 (clone BM8, BioLegend), anti-CD11b (M1/70, BD), anti-CD11c (HL3, BD), anti-CD206 (c06802, BioLegend; MR5D3, Acris), anti-TNF (MP6-XT22, BioLegend), anti-iNOS (CXNFT, eBioscience) and anti-CD49d (clone PS/2, AbD Serotec, or clone 9C10 (MFR4.B), BioLegend). Cells were analyzed in a FACSCanto II flow cytometer (BD).
Histological analysis. For immunohistochemistry, AT was fixed overnight in 10% formalin solution, embedded in paraffin and cut into 5-µm sections 59 . For adipocyte size determination, images of H&E-stained SAT or VAT sections were obtained and the diameter of ~200 adipocytes per slide was measured with the AxioVision Rel. 4.8 software (Carl Zeiss MicroImaging). The diameters of both height and width were measured from each cell. For UCP1 or F4/80 immunohistochemistry, sections were de-paraffinized and incubated with pronase (Sigma Aldrich) or citrate buffer, respectively. Sections were then incubated overnight with anti-UCP1 (Abcam; catalog # ab10983) or anti-F4/80 (Novus Biologicals; catalog # NB600-404). The Vectastain ABC kit (Vector Laboratories) was used for UCP1 or F4/80 detection. Images were obtained by a computerized microscope (Zeiss) or an Axioscan.Z1 slide scanner (Zeiss). Quantification of CLSs was performed in whole-section F4/80-stained mosaic images by counting of CLSs per mm 2 of tissue in six sections per sample. Determination of the number of non-CLS-associated macrophages was performed by counting of F4/80 + cells per 100 adipocytes from ten random low-magnification CLS-free fields per sample. The Zen Imaging Software (Zeiss) was used in both types of quantification.
For immunofluorescence detection of macrophages (F4/80 staining) and adipocytes (caveolin-1 staining) 6, 28 in SAT, whole mounts were prepared. lysis buffer (150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS and 50 mM Tris-HCl, pH 7.5) containing a protease and phosphatase inhibitor cocktail (Roche). After centrifugation, separation by SDS-PAGE and transfer to PVDF membranes, immunoblot analysis was performed with primary antibodies to UCP1 (Abcam; catalog # ab10983), vinculin (Cell Signaling; catalog # 4650) or actin (Santa Cruz Biotechnology; catalog # sc-1616-R). After incubation with secondary antibody (goat antirabbit IgG HRP-conjugated antibody from R&D Systems, HAF008), proteins were detected by using the SuperSignal West Pico Chemiluminescent substrate (Thermo Scientific).
Real-time PCR. White and brown fat tissues were snap-frozen in liquid nitrogen. The samples were homogenized by Precellys 24 beads in Trizol (Invitrogen) and total RNA was isolated. In addition, RNA from cell cultures or from cells isolated from fat tissues was also extracted by Trizol. RNA was reverse-transcribed with the iScript cDNA Synthesis Kit (Bio-Rad). qPCR was performed with SsoFast EvaGreen Supermix (Bio-Rad) and genespecific primers (mouse primers, Supplementary Table 1; human primers (Fig. 7h,j), Supplementary Table 2 ) in a CFX384 Real time PCR detection system (Bio-Rad). Relative mRNA expression was calculated according to the ∆∆Ct method 65 upon normalization to 18S rRNA 66, 67 or ACTB.
Statistical analysis. Statistical tests used are indicated in figure legends. For statistical comparisons, data were analyzed by a Student's t-test or a MannWhitney U test, as appropriate. A one-tailed Pearson correlation analysis was performed for the association between VCAM1 expression and UCP1 expression in human AT samples. For metabolic cage analysis, a one-way analysis of covariance was conducted in conjunction with a Bonferroni post-hoc test. The body weight was used as the covariate. Graph Pad Prism 6 or the IBM SPSS statistics 22 were used. Significance was set at P < 0.05.
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